8 ASX All Ords shares just upgraded to strong buy status

Looking for investment inspiration?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX All Ords Index (ASX: XAO) shares are in the green, up 0.4% as earnings season continues on Tuesday.

Meantime, brokers have identified some stocks that they think are good buys for the year ahead.

Let's check them out.

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market

Image source: Getty Images

8 ASX All Ords shares with strong buy consensus ratings

The following stocks have been recently upgraded to 'strong buy' consensus ratings among analysts on the CommSec platform.

A consensus rating is the average rating based on a number of analysts' opinions.

Zip Co Ltd (ASX: ZIP)

The Zip share price is $2.50, down 0.4% on Tuesday.

This ASX All Ords financial share is up 2% over the past 12 months.

UBS is among the brokers recommending investors buy Zip shares.

The broker has a 12-month share price target of $5.20 on the buy now, pay later (BNPL) provider.

Citi also has a buy rating with a much lower target of $4.30.

Zip will report its earnings on Thursday.

Xero Ltd (ASX: XRO)

The Xero share price is at a three-year low of $77, down 2.7% today as the global tech downturn continues.

The ASX All Ords tech share has halved in value over the past six months.

In February, several brokers have reiterated their buy ratings but with vastly different 12-month price targets.

Jefferies has a target of $82.70 and Citi is tipping $144.80 per share.

WiseTech Global Ltd (ASX: WTC)

The Wisetech share price is also at a three-year low of $45.49, down 5.6% on Tuesday.

Wisetech shares have lost 63% of their value over the past year.

This month, Jefferies reiterated its buy rating with a 12-month price target of $65.

Citi is far more ambitious with a target of $109.15.

Wisetech will release its 1H FY26 results next Wednesday.

Westgold Resources Ltd (ASX: WGX)

The Westgold Resources share price is currently $7.20, down 0.8%.

The ASX All Ords gold share is up 193% over the past 12 months.

Macquarie is among the brokers with a buy rating on Westgold shares. Its 12-month target is $9.90.

Ord Minnett also has a buy recommendation with a target of $8.65.

Some experts believe the gold price could rise above US$7,000 per ounce this year.

Capricorn Metals Ltd (ASX: CMM)

This ASX All Ords gold share is $13.32 apiece on Tuesday, down 0.9%.

Capricorn Metals shares have soared 68% over the past 12 months.

This month, Macquarie upgraded its rating to buy and lifted its price target from $15.20 to $16.20.

AGL Energy Ltd (ASX: AGL)

The AGL share price is $10.43, down 0.6% today and down 2.7% over the past 12 months.

Last week, AGL reported an underlying profit of $353 million for 1H FY26, down 6% on 1H FY25.

The energy retailer announced a fully franked interim dividend of 24 cents per share.

Citi has a buy rating on the ASX All Ords utilities share with a price target of $11.80. 

RBC Capital also has a buy recommendation with a target of $11.50.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price is $8.33, down 3.5% on Tuesday.

The ASX All Ords healthcare share is down 70% over the past 12 months.

Citi just reiterated its buy rating on Telix with a price target of $34.

TD Cowen also has a buy rating but lowered its price target from $25 to $20.

WA1 Resources Ltd (ASX: WA1)

This ASX All Ords copper share is $15.62 apiece, down 2% today and up 18% over the past 12 months.

Copper is in high demand due to the green energy transition and rising debasement trade amid geopolitical and trade uncertainties.

The red metal is essential for electrification and a key input in new infrastructure like wind turbines and data centres.

This month, Canaccord Genuity reiterated its buy rating and lifted its 12-month price target from $28 to $32.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, Telix Pharmaceuticals, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, WiseTech Global, and Xero. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Up 13%: Why this ASX 200 stock is a buy with even more upside

Bell Potter is urging investors to buy this gaming tech stock following its results.

Read more »

A graphic showing three hands holding red paddles with the word BID, indicating a bidding war for an ASX share company
Broker Notes

9 ASX 200 shares with renewed buy calls from the experts this week

Brokers retained a positive view on IAG, NAB, CSL and other shares this week.

Read more »

Young couple at the counter of a hardware store.
Broker Notes

3 compelling reasons to buy BWP shares today

A leading analyst believes Bunnings landlord BWP Trust is well-positioned amid growing market uncertainty.

Read more »

Rocket going up above mountains, symbolising a record high.
Broker Notes

2 ASX mining shares tipped by experts to rocket 55% to 85%

One is a copper miner, the other is an iron ore producer.

Read more »

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

3 ASX 200 shares predicted to double over 12 months

These stocks are on a different trajectory to the ASX 200, which has slipped into the red for 2026.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

3 reasons this beaten down ASX All Ords healthcare share could come roaring back

A leading analyst believes this beaten down ASX healthcare stock is well-positioned for a comeback.

Read more »

A mother and her young son are lying on the floor of their lounge sharing a tech device.
Broker Notes

Does Bell Potter think the Life360 share price is dirt cheap?

Is growing tech stock in the buy zone? Let's find out.

Read more »